FR2239995B1 - - Google Patents

Info

Publication number
FR2239995B1
FR2239995B1 FR7426759A FR7426759A FR2239995B1 FR 2239995 B1 FR2239995 B1 FR 2239995B1 FR 7426759 A FR7426759 A FR 7426759A FR 7426759 A FR7426759 A FR 7426759A FR 2239995 B1 FR2239995 B1 FR 2239995B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7426759A
Other versions
FR2239995A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of FR2239995A1 publication Critical patent/FR2239995A1/fr
Application granted granted Critical
Publication of FR2239995B1 publication Critical patent/FR2239995B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7426759A 1973-08-02 1974-08-01 Expired FR2239995B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3669173A GB1451798A (en) 1973-08-02 1973-08-02 Prostanoic acid derivatives

Publications (2)

Publication Number Publication Date
FR2239995A1 FR2239995A1 (fr) 1975-03-07
FR2239995B1 true FR2239995B1 (fr) 1978-07-21

Family

ID=10390378

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7426759A Expired FR2239995B1 (fr) 1973-08-02 1974-08-01

Country Status (24)

Country Link
US (1) US3954881A (fr)
JP (1) JPS5069045A (fr)
AR (1) AR204013A1 (fr)
AT (1) AT341119B (fr)
BE (1) BE818396A (fr)
CH (1) CH605511A5 (fr)
CS (1) CS174785B2 (fr)
DD (1) DD114401A5 (fr)
DE (1) DE2437388A1 (fr)
DK (1) DK410174A (fr)
EG (1) EG11489A (fr)
ES (1) ES428889A1 (fr)
FI (1) FI232274A (fr)
FR (1) FR2239995B1 (fr)
GB (1) GB1451798A (fr)
IE (1) IE40157B1 (fr)
IL (1) IL45299A (fr)
IN (1) IN138940B (fr)
LU (1) LU70639A1 (fr)
NL (1) NL7410343A (fr)
NO (1) NO742713L (fr)
SE (1) SE7409930L (fr)
ZA (1) ZA744509B (fr)
ZM (1) ZM12074A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183870A (en) * 1974-01-26 1980-01-15 May & Baker Limited Cyclopentane derivatives
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives
GB1506816A (en) * 1975-03-31 1978-04-12 Upjohn Co Prostaglandins
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4388457A (en) * 1982-02-11 1983-06-14 University Patents, Inc. Phyllanthostatin compounds
KR920701229A (ko) * 1989-03-28 1992-08-11 원본미기재 에리트로마이신 유도체
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6184250B1 (en) * 1993-08-03 2001-02-06 Alcon Laboratories, Inc. Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5721273A (en) 1993-12-15 1998-02-24 Alcon Laboratories, Inc. Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension
PT1008588E (pt) * 1997-02-10 2003-09-30 Ono Pharmaceutical Co Derivados da 11,15-o-diaklquil-prostaglandina e processo de producao dos mesmos e farmaco que os contem como ingrediente activo
NZ531139A (en) * 2001-08-29 2007-09-28 Neose Technologies Inc Synthetic ganglioside derivatives and compositions thereof
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US20070026485A1 (en) 2003-04-09 2007-02-01 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1771066A2 (fr) 2004-07-13 2007-04-11 Neose Technologies, Inc. Remodelage de peg ramifie et glycosylation de peptide-1 semblable a glucagon glp-1
EP2586456B1 (fr) 2004-10-29 2016-01-20 ratiopharm GmbH Remodelage et glycopégylation de facteur de croissance de fibroblaste (FGF)
EP1814569A2 (fr) * 2004-11-09 2007-08-08 Neose Technologies, Inc. Glycolipides
AU2006203792B2 (en) 2005-01-10 2011-11-03 Ratiopharm Gmbh Glycopegylated Granulocyte Colony Stimulating Factor
EP2386571B1 (fr) 2005-04-08 2016-06-01 ratiopharm GmbH Compositions et méthodes utilisées pour la préparation de mutants par glycosylation de l'hormone de croissance humaine résistant à la protéase
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (fr) 2005-11-03 2007-05-18 Neose Technologies, Inc. Purification de sucre de nucleotide en utilisant des membranes
US20080242607A1 (en) 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
EA017770B1 (ru) 2007-04-03 2013-03-29 Биодженерикс Аг Способы лечения с использованием гликопэгилированного g-csf
CN101778859B (zh) 2007-06-12 2014-03-26 诺和诺德公司 改良的用于生产核苷酸糖的方法
CN103497246B (zh) 2008-02-27 2016-08-10 诺沃—诺迪斯克有限公司 缀合的因子viii分子
EP3175857A1 (fr) 2009-03-25 2017-06-07 Seneb Biosciences Inc. Glycolipides en tant que traitement de maladies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1334952A (en) * 1971-01-06 1973-10-24 Ici Ltd Cyclopentane derivat-ves and a process for their manufacture

Also Published As

Publication number Publication date
LU70639A1 (fr) 1974-12-10
AU7163574A (en) 1976-01-29
US3954881A (en) 1976-05-04
AR204013A1 (es) 1975-11-12
ATA635674A (de) 1977-05-15
IL45299A (en) 1978-06-15
ES428889A1 (es) 1976-09-01
IN138940B (fr) 1976-04-17
CS174785B2 (fr) 1977-04-29
JPS5069045A (fr) 1975-06-09
IE40157L (en) 1975-02-02
BE818396A (fr) 1975-02-03
NL7410343A (nl) 1975-02-04
FR2239995A1 (fr) 1975-03-07
DE2437388A1 (de) 1975-02-13
EG11489A (en) 1978-06-30
DK410174A (fr) 1975-04-01
CH605511A5 (fr) 1978-09-29
AT341119B (de) 1978-01-25
ZM12074A1 (en) 1976-11-22
FI232274A (fr) 1975-02-03
GB1451798A (en) 1976-10-06
IE40157B1 (en) 1979-03-28
NO742713L (fr) 1975-03-03
SE7409930L (fr) 1975-02-03
IL45299A0 (en) 1974-10-22
DD114401A5 (fr) 1975-08-05
ZA744509B (en) 1975-07-30

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
FR2239995B1 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AR199451A1 (fr)
AR201432A1 (fr)
AR196382A1 (fr)
AR195948A1 (fr)
AR195311A1 (fr)
AR197627A1 (fr)
AR210729A1 (fr)
AR200885A1 (fr)
AR193950A1 (fr)
AU447540B2 (fr)
AR200256A1 (fr)
AR196212Q (fr)
AR196123Q (fr)

Legal Events

Date Code Title Description
ST Notification of lapse